Holdings over time
(Since March 12, 2024)
Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
---|---|---|---|---|
Novo Nordisk (NOVO-B.CO) | 18.69% | 0% | 99.69% | 2/1/2025 |
LVMH (MC.PA) | 12.85% | 0% | 99.69% | 2/1/2025 |
ASML (ASML.NV) | 11.66% | 0% | 99.69% | 2/1/2025 |
SAP (SAP.DE) | 9.19% | 0% | 99.69% | 2/1/2025 |
Nestle (NESN.ZU) | 8.94% | 0% | 99.69% | 2/1/2025 |
Novartis (NVS) | 8.14% | 0% | 99.69% | 2/1/2025 |
Roche (ROG.ZU) | 8.05% | 0% | 99.69% | 2/1/2025 |
L'Oréal (OR.PA) | 7.76% | 0% | 99.69% | 2/1/2025 |
AstraZeneca (AZN) | 7.64% | 0% | 99.69% | 2/1/2025 |
Sanofi (SAN.PA) | 4.43% | 0% | 99.69% | 2/1/2025 |
GlaxoSmithKline (GSK) | 2.72% | 0% | 99.69% | 2/1/2025 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
Instrument | Invested | Value |
---|---|---|
Novo Nordisk (NOVO-B.CO) | 19.06% | 16.25% |
LVMH (MC.PA) | 14.66% | 13.73% |
SAP (SAP.DE) | 7.44% | 12.07% |
ASML (ASML.NV) | 12.53% | 11.62% |
Roche (ROG.ZU) | 7.11% | 9.15% |
Nestle (NESN.ZU) | 9.11% | 8.87% |
Novartis (NVS) | 7.33% | 8.56% |
L'Oréal (OR.PA) | 8.36% | 7.86% |
AstraZeneca (AZN) | 6.54% | 7.74% |
Sanofi (SAN.PA) | 3.91% | 4.99% |
GlaxoSmithKline (GSK) | 2.81% | 2.69% |